Doctor from Animal Husbandry Department to be part of ABC programme in Salem Corporation
Salem Corporation has two ABC centres at Shevapet in the Suramangalam zone and Ponnammapet in the Ammapet zone. Four vehicles are used and 20 trained Corporation staff are involved in capturing stray dogs. The sterilisation of dogs was stopped in Salem Corporation during the COVID-19 pandemic. It resumed in 2022 and 750 to 1,100 dogs were sterilised through an animal welfare charity at the Ponnammapet ABC centre on Veeranam Main Road every month.
The Corporation spent ₹1,650 per dog (₹200 for capturing and ₹1,450 for works related to sterilisation). The contract period with the charity ended on January 31 and following this, the ABC centres remained closed.
Councillors raised this issue at the Corporation council meeting and demanded the Corporation to resume the sterilisation programme at the ABC centres. The Corporation, through the District Collector, asked the Animal Husbandry Department to allocate doctors to resume the ABC programme. Based on that, a doctor from the Animal Husbandry Department was allocated for the ABC programme.
Corporation Commissioner M. Elangovan said the civic body would spend ₹1,000 per dog, including capturing the dog and providing required medicines. Within a week, the ABC programme would resume, he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Delhi may conduct a stray dog census soon
Delhi may soon see a census of stray dogs in the Capital. This is one of many measures that the panel formed by the Municipal Corporation of Delhi's Standing Committee earlier this month, amid an outcry over rising cases of stray dog bites, has planned to take. The committee, which held its second meeting on Monday, gathered suggestions from the MCD, doctors from government hospitals, NGOs running 20 sterilisation shelters, animal welfare experts, and dog lovers. Sub-committee chairperson, Sunder Singh Tanwar, said a monitoring team will be formed to inspect one shelter a week and look at sterilisation records. 'We'll see if the shelter has enough rabies injections, look at its sanitation conditions, if an infected dog is kept isolated, and check records of sterilisation,' he said, adding that RWAs will also be roped in to carry out the measures. Officials said the civic body, in collaboration with various NGOs, plans to implant a microchip in every dog at sterilisation centres. The chip will record details of their sterilisation status and other vital information, enabling effective monitoring and tracking in the future. Former BJP MP and founder of People for Animals, Maneka Gandhi, who was also present at the meeting, emphasised the need to upgrade and equip the ABC (animal birth control) centres run by the corporation, improve existing medical facilities, and train staff. Tanwar said dog lovers demanded that the Delhi government and civic body-run hospitals should function 24×7 and provide special attention and care to dogs who meet with accidents. Animal welfare expert Gauri Maulekhi, who was also part of the meeting, said, 'The 'nexus' between several ABC centres and MCD officials concerned was formally brought to the attention of the Standing Committee's chairperson.' She also alleged that there's no information on veterinarians working at ABC centres on the MCD website. Her recommendations to the committee included: robust monitoring, infrastructure upgradation, civil society participation, capacity-building, and transparent fund utilisation. 'We remain hopeful that the Standing Committee will rise above decades of bureaucratic inertia and initiate meaningful implementation of the law,' she added. Satya Sharma, Standing Committee Chairperson, said the MCD aims to adopt a holistic approach to strike a balance between animal welfare and public health. 'We are taking strong and effective steps in this direction with the support of all agencies concerned and experts to resolve the issue of stray dogs.' Last month, the Supreme Court had taken suo motu cognizance of a report about infants in Delhi falling prey to the menace. Three big hospitals in the Capital — Safdarjung Hospital, Dr Ram Manohar Lohia Hospital and Hindu Rao Hospital — are witnessing a surge in the cases of dog bites over the last few years. Data accessed by The Indian Express had shown that Centre-run Safdarjung Hospital saw a massive surge in dog bite cases this year when compared to the figures in 2021. While 63,361 cases were reported in the entire year in 2021, the hospital has already registered 91,009 cases till July this year
The Hindu
2 hours ago
- The Hindu
India's pandemic toll remains elusive
The Civil Registration System (CRS) data has brought into sharp relief the magnitude of excess mortality that India witnessed during the COVID-19 pandemic years. Excess mortality refers to the difference between the total number of deaths during a pandemic or any other natural disaster compared to the number of deaths that would have been expected under normal conditions. According to the CRS, India recorded 76.4 lakh deaths in 2019. This figure rose to 81.11 lakh in 2020 and further surged to 1.02 crore in 2021 — an implicit acknowledgement of the fact that the true mortality impact of COVID-19 far exceeds the official toll of 5.33 lakh. Data from the Medical Certification of Cause of Death (MCCD) for 2021, released alongside the CRS and Sample Registration System reports, adds further weight to this claim. COVID-19 was identified as the second leading cause of death, with 5.74 lakh certified fatalities attributed to the virus — already exceeding the official figure. However, this estimate was drawn from less than a quarter (23.4%) of registered deaths in 2021. Taken together, the rise in all-cause mortality and the limited scope of medical certification offer a compelling case that India's true pandemic death toll may be far closer to the World Health Organization's estimate of 47 lakh deaths — a model that the Government of India had earlier rejected, citing concerns over its methodological robustness. A systemic deficiency CRS data/all-cause mortality data is indispensable, especially given the widespread undercounting of COVID-related deaths. This metric captures not only confirmed cases but also fatalities arising from misdiagnoses, misclassification, and pandemic-induced systemic disruptions. Nonetheless, the utility of the all-cause mortality data in gauging the true impact of COVID-19 is limited in the Indian setting, as the recording of deaths is far from universal. The National Family Health Survey-5 states that nearly 29% of deaths between 2016 and 2020 went unregistered. The omission of civil registration from the list of essential services during the 2020 lockdown further obscured the mortality landscape. As a consequence, even comprehensive datasets such as CRS may fall short in reflecting the full impact of the pandemic. Editorial | A belated admission: On the undercount of India's COVID-19 pandemic deaths Beyond numerical discrepancies lies a deeper issue — the structural inadequacy of death certification and classification. During the pandemic years, we visited crematoriums and burial grounds in a locality in Kerala. We observed a marked rise in the number of daily cremations compared to previous years — an increase that was evident not only in facilities designated for handling COVID-19 deaths, but also in those without such designation. This raises pertinent questions regarding the misclassification of COVID-19 deaths and under-ascertainment of causes. A significant driver of this opacity is the absence of medical certification. In 2020, 45% of deaths occurred without any form of medical attention — 10% points higher than in pre-pandemic years. Within our study cohort, only 22.8% of the deceased had any formal medical documentation indicating the cause of death. Nationally, only 23.4% of deaths are medically certified as per the recent MCCD data. This systemic deficiency compromises mortality surveillance as well as public health planning. Indirect deaths A further dimension of the pandemic's mortality burden relates to indirect deaths — a category of deaths that, while not directly caused by SARS-CoV-2 infection, can be reasonably attributed to the wider repercussions of the pandemic. These fatalities, often absent from COVID-19 official statistics, occurred due to systemic disruptions: delays in seeking care due to fear of infection, scarcity of hospital beds and essential medicines, post-infection complications, economic distress, and logistical barriers to healthcare access during prolonged lockdowns. During our field study, we found that a considerable share of deaths was indirectly linked to these cascading effects of the pandemic. Many people suffered physical and psychological deterioration post-infection, some experienced an exacerbation of chronic conditions, and others refrained from seeking timely medical attention. When extrapolated to the broader national context, particularly in regions where healthcare systems are fragile and supply chains were acutely disrupted, the implications would be sobering. To gauge the true mortality impact of the pandemic, it is insufficient therefore to rely solely on officially recorded COVID-19 deaths or all-cause mortality data. Also read | 'Excess deaths in 2020 and 2021 not equal to deaths by COVID-19, increase attributable to several reasons' Our study in Kerala found that 34% of deaths were indirectly attributable to the pandemic, and 9% may have been misclassified. If such patterns exist in a State with a relatively strong public health systems (although the death registration in the prescribed time was around 61% in 2021), the scale of undercounting could be even more pronounced in States such as Gujarat and Madhya Pradesh where discrepancies between excess deaths and official figures are significantly wider. These findings make a compelling case for a systematic inquiry into the full extent of mortality during the pandemic. Policymakers should consider conducting a large-scale study, which could be also accomplished by including questions on decedents in the next Census. More importantly, they must serve as a wake-up call to urgently reform India's mortality surveillance architecture. Shilka Abraham, Master of Public Health graduate, School of Health Systems Studies, Tata Institute of Social Sciences; Soumitra Ghosh, Associate Professor and Chairperson, Centre for Health Policy, Planning and Management, School of Health Systems Studies, Tata Institute of Social Sciences
Hindustan Times
6 hours ago
- Hindustan Times
A Turning Point in Colon Cancer: Young People Are Finding It Earlier
People under age 50 have been appearing increasingly at doctor's offices in the past few decades, complaining of blood in their stool or bowel or of abdominal trouble or unexplained weight loss. The diagnosis: colorectal cancer . And by that time, it was often too late. But that paradigm is finally starting to shift, at least for patients in their 40s. There has been a jump in people aged 45 to 49 getting screened for colorectal cancer, after recent medical guidelines lowered the screening age for those at average risk. As a result, the disease is being caught sooner, when it is more curable and the treatment is less grueling, according to new research from the American Cancer Society. The recent screening recommendations designed to catch cases sooner appear to be working. 'It's thrilling to see this,' said Rebecca Siegel, an epidemiologist at the ACS and an author of the new research. 'It means fewer deaths and higher quality of life for people who are diagnosed.' The findings come in a flurry of research published Monday in the Journal of the American Medical Association. Colorectal cancer screening in the U.S. for adults age 45 to 49 increased by 62% from 2019 to 2023, according to one ACS paper. Early-stage diagnoses then surged, including a 50% relative increase from 2021 to 2022, according to another ACS report. A trial of more than 20,000 people in the same age bracket was published by a separate group of researchers, showing that testing uptake increases when people are mailed stool tests by default, versus when they are asked if they want a test or a colonoscopy. Screening rates in the trial were low, however, with 19% of people in the trial overall opting to get screened. 'We probably shouldn't be wasting time asking patients first; we should send them what they need,' said Dr. Folasade May, the trial's senior author and a gastroenterologist at the University of California, Los Angeles. 'We have a long way to go.' Colorectal cancer rates have been rising for people under age 50 since the 1990s, and the disease is now the leading cause of cancer death among men in that group. Researchers are investigating everything from diet and lifestyle to environmental contaminants, to figure out why colorectal and other cancers are rising in younger adults. The ACS in 2018 started recommending that people with average risk as young as 45 years old get screened for colorectal cancer, down from the previous start of age 50. The U.S. Preventive Services Task Force followed in 2021; their guidelines carry particular weight among primary-care providers and often lead to health-insurance coverage. Suddenly, millions of people were newly overdue for screening. For people in that 45-to-49 age bracket, cases jumped, going from about a 1% increase in the incidence rate each year since 2004 to a 12% annual rise from 2019 to 2022, the data show. The rise was driven by diagnoses of early-stage disease. A post-Covid rebound in people seeking healthcare could contribute to some of the increase, researchers said, but the change in screening guidance is likely the bigger factor. The trend looks similar to what happened among people ages 50 and above in the late 1990s, after screening was first recommended for them, said Caitlin Murphy, a cancer epidemiologist and professor of pediatrics at the University of Chicago, who wasn't involved in the studies. It will still take time to see what the impact on deaths looks like for the newly eligible, she said. 'Ultimately, the goal of screening is to reduce mortality, and we haven't seen that quite yet, simply because not enough time has gone by.' Up-to-date screening via colonoscopy for those aged 45 to 49 rose from around 20% of people in 2019 to about 28% in 2023, according to one of the ACS reports. A colonoscopy is the gold-standard test that also helps doctors remove polyps to actually prevent the cancer from forming. Alternatively, use of tests that look for blood or DNA changes in the stool also increased, rising from 1.3% to 7.1% in that age group. Screening rates remained mostly stable in all other age groups, the report found. Screening rates also remained unchanged for people ages 45 to 49 with less than a high-school education or who are uninsured. And they still trail behind those for older adults, who remain at higher risk. Factors including genetics, excess body weight, smoking cigarettes and a diet heavy in red and processed meats also increase a person's odds of developing the disease. People in the 45-to-49 age bracket account for nearly half of all colorectal cancers under age 50, ACS said. But that still leaves a lot of people who are at risk and are too young to be screened. 'I have patients in their 20s in my practice that would never fit the guidelines,' said Dr. Michael Cecchini, a medical oncologist and colorectal cancer specialist at Yale Cancer Center. 'We need to be thinking about it on our list of possible diagnoses.' Write to Brianna Abbott at
